+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

China Probiotics Market - Forecasts from 2022 to 2027

  • PDF Icon

    Report

  • 78 Pages
  • December 2022
  • Region: China
  • Knowledge Sourcing Intelligence LLP
  • ID: 5716726
China probiotics market is projected to grow at a CAGR of 12.23% to reach US$20,835.868 million by 2027, from US$9,292.021 million in 2020.

Probiotics are living microorganisms that have health benefits when they are either consumed or applied to the body. Probiotics contain good bacteria that help in digesting food, destroy disease-causing cells, and produce vitamins. They also help in maintaining a healthy balance in the body. Naturally, probiotics are found in yogurt. The food and drug administration (FDA) regulates probiotics like foods, and not like medications. Probiotic intake is considered healthy and a smart choice among them due to its clinically proven health benefits.

The increased role of probiotics in China

After the economic reforms of 1978, the country’s GDP growth averaged over 9 percent a year. Significant improvements in access to health, education, and other services have taken place. Therefore, with such awareness programs and initiatives, life expectancy in China has reached 77, as of 2020, as per World Bank.

Due to the increased importance of probiotics, many research studies and trials have also taken place in order to understand their efficiency and future prospects. For example, in November 2021, the human trial for understanding the effect of yeast-based probiotics was done. The study was conducted by Hua Zhong University of Science and Technology. Furthermore, the trials were done on adults who were suffering from inflammatory bowel disease (IBD). Saccharomyces boulardii bld-3 was the yeast-based probiotic that was tested, the angel yeast-based probiotic is specially designed to address diarrhea problems and improve digestion.

Moreover, according to World Bank Data, China’s old-age dependency ratio reached 18% in 2021, from 10% in the year 2006. This is primarily due to the one-child policy of the country. This is fueling the demand for probiotics as probiotic supplements may be effective in counteracting age-related shifts as they help to restore the natural diversity of human gut bacteria, strengthen the immune system, and positively impact cognition and mood which impacts health outcomes and promote healthy aging.

Market Developments

Therefore, the market players are making mindful investments and launches to expand the product offering for the market. For instance,
  • In June 2020, China added three probiotic strains to its new food raw material list. The three approved probiotic strains were Lactobacillus helveticus R0052, bifidobacterium infantis r0033, and bifidobacterium bifidum r0071. Moreover, till April 2020, 137 health food that contains probiotic as their main ingredient has been approved in the country, according to Chemical Inspection and Regulation Service (CIRS), China.

COVID 19 Insights

The COVID-19 pandemic caused millions of deaths worldwide. It severely hampered the immunity of individuals. However, the pandemic had a positive impact on the Chinese probiotics market. As probiotics are known to restore a stable gut microbiota by regulating innate and adaptive immunity within the gut, they were used to combat COVID-19 because of several pieces of evidence that suggested that COVID-19 has an adverse impact on gut microbiota dysbiosis. Thus probiotics were used for their antiviral properties as an adjunctive treatment to combat COVID-19. Several clinical trials were also undertaken, which proved the efficacy of probiotics and their metabolites in treating patients with the virus.

Market Segmentation:

  • By Type
  • Lactobacillus
  • Streptococcus
  • Bifidobacterium
  • Spore Formers
  • Others
  • By Form
  • Liquid
  • Dry
  • By Application
  • Functional Food and Beverages
  • Dietary Supplements
  • Animal Feed
  • By End-User
  • Human
  • Animal
Frequently Asked Questions about the Chinese Probiotics Market

What is the estimated value of the Chinese Probiotics Market?

The Chinese Probiotics Market was estimated to be valued at $9292.02 million in 2020.

What is the growth rate of the Chinese Probiotics Market?

The growth rate of the Chinese Probiotics Market is 12.2%, with an estimated value of $20835.87 million by 2027.

What is the forecasted size of the Chinese Probiotics Market?

The Chinese Probiotics Market is estimated to be worth $20835.87 million by 2027.

Who are the key companies in the Chinese Probiotics Market?

Key companies in the Chinese Probiotics Market include Yakult, Danone, Probi AB and Yili Group.

Table of Contents

1. INTRODUCTION
1.1. Market Overview
1.2. COVID-19 Scenario
1.3. Market Definition
1.4. Market Segmentation

2. RESEARCH METHODOLOGY
2.1. Research Data
2.2. Assumptions

3. EXECUTIVE SUMMARY
3.1. Research Highlights

4. MARKET DYNAMICS
4.1. Market Drivers
4.2. Market Restraints
4.3. Porter's Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis

5. CHINA PROBIOTICS MARKET, BY TYPE
5.1. Introduction
5.2. Lactobacillus
5.3. Streptococcus
5.4. Bifidobacterium
5.5. Spore Formers
5.6. Others

6. CHINA PROBIOTICS MARKET, BY FORM
6.1. Introduction
6.2. Liquid
6.3. Dry

7. CHINA PROBIOTICS MARKET, BY APPLICATION
7.1. Introduction
7.2. Functional Food & Beverage
7.3. Dietary Supplements
7.4. Animal Feed

8. CHINA PROBIOTICS MARKET, BY END-USER
8.1. Introduction
8.2. Human
8.3. Animal

9. COMPETITIVE ENVIRONMENT AND ANALYSIS
9.1. Major Players and Strategy Analysis
9.2. Emerging Players and Market Lucrativeness
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Vendor Competitiveness Matrix

10. COMPANY PROFILES
10.1. Yakult
10.2. Danone
10.3. Probi AB
10.4. Pantheryx, Inc.
10.5. Yili Group
*List is not exhaustive

Companies Mentioned

  • Yakult
  • Danone
  • Probi AB
  • Pantheryx, Inc.
  • Yili Group